Blue Trust Inc
RNTX icon

Blue Trust Inc’s Rein Therapeutics RNTX Stock Holding History

Blue Trust Inc’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16 Hold
20
– – ﹤0.01% 2501
2026
Q2 		$21 Hold
20
– – ﹤0.01% 2436
2026
Q1 		$26 Hold
20
– – ﹤0.01% 2485
2025
Q4 		$23 Hold
20
– – ﹤0.01% 2524
2025
Q3 		$23 Hold
20
– – ﹤0.01% 2559
2025
Q2 		$28 Hold
20
– – ﹤0.01% 2434
2025
Q1 		$35 Buy
+20
New +$42 ﹤0.01% 2459

Other funds holding RNTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $798M AUM 22.92% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Rock Creek Group
Rock Creek Group Washington, District of Columbia $1.04B AUM 6.61% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return
Rossby Financial
Rossby Financial Melbourne, Florida $673M AUM 21.47% 1-Year Est. Return
Savant Capital
Savant Capital Rockford, Illinois $35B AUM 15.18% 1-Year Est. Return
Americana Partners
Americana Partners Houston, Texas $4.67B AUM 26.97% 1-Year Est. Return

Blue Trust Inc's RNTX Position: Q3 2026 in Review

Blue Trust Inc held its Rein Therapeutics (RNTX) position steady in Q3 2026 at 20 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Blue Trust Inc first reported a position in RNTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $35 in Q1 2025. 27 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

  • Blue Trust Inc held 20 shares of Rein Therapeutics worth $16 as of Q3 2026.
  • Blue Trust Inc left its Rein Therapeutics share count unchanged in Q3 2026.
  • Rein Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2501 holding.
  • Blue Trust Inc first reported a position in Rein Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Blue Trust Inc's Rein Therapeutics position peaked at $35 in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.